|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase I trialinvolving the pharmacodynamic ( PD) study of circulatingtumour cells, of CP - 7 5 1 8 7 1 , a monoclonal antibody againstthe insulin - like growth factor 1 receptor ( IGF -1R ),with docetaxel ( D) in patients with advanced cancer显示文摘 | ATTARD G FONG P C MOLIFE R | | JC lin Oncol0，22，9： | 1 |
| 2 | A phase Ⅰ dose escalation study of AT9283,a small molecule inhibitor of aurora kinases in patients with advanced solid malignancies显示文摘 | ARKENAU H T PLUMMER R MOLIFE L R | 2012 | Ann Oncol2012，23，5： | 1 |
| 3 | A phase I pharmaco-' kinetic and pharmacodynamic study of TKI258, an ora, 1 muhitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors 显示文摘 | Sarker D Molife R Evans T R J | 2008 | Clin Cancer Res2008，14，7： | 1 |
| 4 | A pha- se I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies 显示文摘 | ARKENAU H T PLUMMER R MOLIFE L R | 2012 | Ann Onco12012，23，5： | 1 |
| 5 | A phase Ⅰ pharmacokinetic and pharmacodynamic study of TKI258, an oral, muhitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors 显示文摘 | SARKER D MOLIFE R EVANS TRJ | 2008 | Clin Cancer Res2008，14，7： | 1 |
| 6 | Phase II study of eribu- lin mesylate( E7389 )in patients with metastatic castration -resistant prostate cancer stratified by prior taxane therapy 显示文摘 | de Bonn J S Molife L R Sonpavde G | 2012 | Annals of On- cology2012，23，5： | 1 |
| 7 | Adjuvant therapy of malignant mlanoma显示文摘 | Molife R Hancock BW | 2002 | Crit Rev Oncol Hematol2002，44，： | 1 |
| 8 | Adjuvant therapy of malignant melanoma 显示文摘 | Molife R Hancock BW | 2002 | Crit Rev Oncol Hematol2002，44，1： | 1 |
| 9 | Phase 1trial of the oral AKT inhibitor MK-2206 plus carbopl- ativJpaclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors显示文摘 | Molife L R Yan L Vitfell-Rasmussen J | 2014 | Journal of Hematology & Oncology2014，7，： | 1 |
| 10 | A phase 1 dose escalation study of at9283, a small molecule inhibitor of aurora kinases, in pa- tients with advanced solid malignancies 显示文摘 | Arkenau HT Plummer R Molife LR | 2012 | Ann Oncol2012，23，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员